INTERNATIONAL CONSTRUCTION CONSULTANCY ACQUIRES RGD PROJECT MANAGEMENT, EXPANDS ADVANCED TECHNOLOGIES DIVISION

Cumming Group, a leading provider of project and cost management advisory services in North America, has announced the merger with RGD Project Management, Inc., a North Carolina-based firm specializing in life sciences manufacturing project management. The deal, which was disclosed on May 15, 2026, will enhance Cumming Group's Advanced Technologies division, although the financial terms of the transaction remain undisclosed.

Founded in 1999, RGD Project Management has established itself as a key player in the life sciences sector, delivering over 2,200 projects for blue-chip pharmaceutical and biotechnology manufacturers. With a workforce of 81 employees, RGD is well-regarded in North Carolina's Research Triangle, a region known for its concentration of life sciences companies and significant investments in biopharmaceutical manufacturing. The merger is expected to significantly bolster Cumming Group's capabilities in this active market, which has seen over $10 billion in recent investments in life sciences manufacturing.

The strategic rationale behind the merger centers on Cumming Group's commitment to expanding its footprint in the biopharmaceutical sector. By integrating RGD's expertise and established client relationships, Cumming Group aims to enhance its service offerings and accelerate its advanced technologies strategy, particularly along the East Coast. This move aligns with the growing demand for specialized project management services in the life sciences industry, where precision and reliability are critical.

Cumming Group's Advanced Technologies division, which now comprises over 700 professionals, will benefit from RGD's deep knowledge and experience in managing complex, schedule-critical projects. The merger is expected to provide RGD's clients with access to a broader range of technical resources and the support of an international organization, while maintaining the trusted, client-focused approach that has defined RGD's operations for over two decades.

The implications of this merger extend beyond the immediate capabilities of Cumming Group and RGD. As the life sciences sector continues to evolve, driven by increasing investments and technological advancements, the consolidation of expertise within this space may lead to more efficient project delivery and enhanced innovation. The integration of RGD into Cumming Group positions the combined entity to capitalize on emerging opportunities in the biopharmaceutical market, potentially setting a precedent for future mergers and acquisitions in the construction and project management sectors.